The Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) announced on Sunday it would offer free home delivery of prescription medications, in response to the state instructions to citizens to stay at home amid the coronavirus outbreak.
It comes through the company’s Save Yourself, Stay Home, Protect your Family, and Protect your Community (SPP) initiative, aimed at reducing elderly and patients with special needs’ risk of exposure to COVID-19.
The initiative will last for three months over three phases, with each phase closely monitored by Rameda to decide on the continuity of the project based on its success to date and the coronavirus pandemic situation in Egypt. The initiative will target those who suffer from non-communicable diseases, namely cardiovascular disease, diabetes, and gastrointestinal disorders, and will provide them with the essential medications they need from Rameda’s products. Each delivery will be conducted in a quick, efficient, and safe manner and will include providing safety tips to patients to protect themselves from coronavirus.
Rameda will work with a large network of more than 400 pre-approved licensed doctors and physicians, who will first determine whether their patients’ health profile matches Rameda’s clearly defined criteria of immunocompromised patients.
These patients are selected by their doctors based on clear, defined criteria to include the elderly, and patients who suffer from the previously mentioned non-communicable diseases. The doctor or physician will then direct eligible patients to send their valid prescription along with their personal information, including name, age, address, and contact, to a designated number. Patients will receive their medication at their residence within three working days through free, contactless delivery.
During the first phase of the project, which has begun on 19 April, more than 165 cardiologists and diabetologists from Rameda’s approved list of physicians across Cairo and Alexandria were invited to take part in the initiative.
The second phase, subject to the success of the first one, will see the project expand to include more than 140 cardiologists and diabetologists from Delta, Suez Canal, and Upper Egypt regions. The third phase will include a further 100 gastroenterologists across Egypt.